| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/14/2011 | CN101416997B Preparation technique of bitter melon powder and cucumber powder |
| 09/14/2011 | CN101347530B Oral liquid for regulating blood fat and blood sugar |
| 09/14/2011 | CN101342312B Medicament for treating pharyngitis and method for preparing the same |
| 09/14/2011 | CN101336931B Iron liposomes used as iron supplementary |
| 09/14/2011 | CN101327308B Chinese herbal medicine for treating hyperosteogeny |
| 09/14/2011 | CN101327266B Oral cavity nursing agent for preventing and treating oral disease induced by Helicobacter pylori infection contamination |
| 09/14/2011 | CN101322720B Arsenic trioxide emulsion for intravenous injection and preparation thereof |
| 09/14/2011 | CN101292991B Compound gelling agent containing clindamycinum |
| 09/14/2011 | CN101279002B Medicament for relieving cough and eliminating phlegm and method of preparing the same |
| 09/14/2011 | CN101269096B Chinese medicine valid target for treating apoplexy disease |
| 09/14/2011 | CN101252908B Stabilized and preserved ketotifen ophthalmic compositions |
| 09/14/2011 | CN101219161B Dracocephalum moldavica extract and dracocephalum moldavica dropping pills, and method of preparing the same |
| 09/14/2011 | CN101204568B Digestion-promoting preparation and preparation method thereof |
| 09/14/2011 | CN101199626B Powders medicament for treating anal eczema |
| 09/14/2011 | CN101195003B Proprietary Chinese medicine for treating apoplexy and sequela |
| 09/14/2011 | CN101185696B Cream shape medicine for treating II or III degree bedsore |
| 09/14/2011 | CN101168050B Immunity regulating medicinal composition |
| 09/14/2011 | CN101129486B Stephaniatetrandran granules for treating hepatopathy and method of preparing the same |
| 09/14/2011 | CN101085305B Vein relaxing plaster for curing cervical vertebra and lumbar vertebra disease |
| 09/14/2011 | CN101053352B Buccal tablet and its preparation method |
| 09/14/2011 | CN101019949B Qingkailing preparation for great transfusion and its preparation process |
| 09/14/2011 | CN101015524B Coenzyme Q10 oral emulsion and preparing process thereof |
| 09/13/2011 | US8019412 Apparatus for facilitating transdermal delivery of therapeutic substances and method of transdermally delivering therapeutic substances |
| 09/13/2011 | US8017727 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/13/2011 | US8017681 Systems and methods for providing a thermoplastic product that includes packaging therefor |
| 09/13/2011 | US8017645 Melatonin daily dosage units |
| 09/13/2011 | US8017627 Fentanyl composition for nasal administration |
| 09/13/2011 | US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2011 | US8017586 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 09/13/2011 | US8017577 Lyophilizable and enhanced compacted nucleic acids |
| 09/13/2011 | US8017156 Long-acting colloidal insulin formulation and its preparation |
| 09/13/2011 | US8017155 Immersing and soaking insoluble pore containing polymer into encapsulating solution containing active ingredient then initiating pore closing rearrangement by adjusting temperature and/or pH |
| 09/13/2011 | US8017154 Polyamino acid for use as adjuvant |
| 09/13/2011 | US8017153 Dietary supplement composition for blood lipid health |
| 09/13/2011 | US8017152 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| 09/13/2011 | US8017151 Amphiphilic polymer-protein conjugates and methods of use thereof |
| 09/13/2011 | US8017150 Polyether combined with hydrophilic cellulosic material; demonstrates non-self-aggregating, uniform heterogeneity; mucosally adhesive water soluble product containing analgesic opiate; preventing air pocket formation during production |
| 09/13/2011 | US8017149 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 09/13/2011 | US8017148 Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent |
| 09/13/2011 | US8017147 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| 09/13/2011 | US8017146 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised |
| 09/13/2011 | US8017145 Exfoliating personal care wipe article containing an array of projections |
| 09/13/2011 | US8017144 Controlled release polymeric compositions of bone growth promoting compounds |
| 09/13/2011 | US8017140 Drug-delivery stent formulations for restenosis and vulnerable plaque |
| 09/13/2011 | US8017135 Lipid-drug conjugates for local therapy of eye diseases |
| 09/13/2011 | US8017106 Aerosol cream mousse and method of treating hair |
| 09/13/2011 | US8017032 Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications |
| 09/13/2011 | US8016979 Chemical solution-containing thin paper |
| 09/13/2011 | US8016817 Device for controlling exposure of reservoir contents to surroundings |
| 09/13/2011 | US8016811 Method for transdermal delivery of permeant substances |
| 09/13/2011 | CA2640451C Medicine for transnasal administration |
| 09/13/2011 | CA2639407C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 09/13/2011 | CA2628857C Formulation and method for treating neoplasms by inhalation |
| 09/13/2011 | CA2525873C Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/13/2011 | CA2513781C Microencapsulation systems and applications of same |
| 09/13/2011 | CA2494959C Embolization |
| 09/13/2011 | CA2467763C Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 09/13/2011 | CA2453779C Cationic alkyd polyesters for medical applications |
| 09/13/2011 | CA2428800C In vivo use of fluid absorbent polymers |
| 09/13/2011 | CA2356637C Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/12/2011 | CA2733694A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733692A1 Selegiline-containing adhesive preparation |
| 09/12/2011 | CA2733633A1 Selegiline-containing adhesive preparation |
| 09/09/2011 | WO2011109403A1 Use of (3r)-4-{[(1s)-2-methyl-1- (2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
| 09/09/2011 | WO2011109384A2 Biodegradable polymers for lowering intraocular pressure |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108644A1 Solid pharmaceutical composition and pharmaceutical preparation |
| 09/09/2011 | WO2011108643A1 Film preparation containing medicament with unpleasant taste |
| 09/09/2011 | WO2011108521A1 Mucosal vaccine |
| 09/09/2011 | WO2011108167A1 Powdered composition, cosmetic material, and method for producing powdered composition |
| 09/09/2011 | WO2011107970A2 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 09/09/2011 | WO2011107945A1 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 09/09/2011 | WO2011107932A1 Drug delivery device |
| 09/09/2011 | WO2011107922A2 Extended release composition of milnacipran |
| 09/09/2011 | WO2011107921A2 Modified release composition of milnacipran |
| 09/09/2011 | WO2011107855A2 Sustained release oral liquid suspension dosage form |
| 09/09/2011 | WO2011107820A1 Surface immobilized chaperones |
| 09/09/2011 | WO2011107812A2 Stabilized pharmaceutical composition |
| 09/09/2011 | WO2011107755A2 Immediate/delayed drug delivery |
| 09/09/2011 | WO2011107750A2 Delayed prolonged drug delivery |
| 09/09/2011 | WO2011107749A2 Pulsatile drug release |
| 09/09/2011 | WO2011107653A2 Method for treating parkinson's disease |
| 09/09/2011 | WO2011107643A1 Liposome-encapsulated bicelles and use thereof in diluted systems |
| 09/09/2011 | WO2011107617A1 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof |
| 09/09/2011 | WO2011107522A2 Foam formulations containing at least one triterpenoid |
| 09/09/2011 | WO2011107436A2 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/09/2011 | WO2011107427A1 Dabigatran etexilate-containing oral pharmaceutical composition |
| 09/09/2011 | WO2011107408A1 Stable pharmaceutical composition comprising bisphosphonate |
| 09/09/2011 | WO2011107283A2 Formulations of taurolidine and method for the production thereof |
| 09/09/2011 | WO2011107259A1 Nutraceutical chocolate or compound chocolate product |
| 09/09/2011 | WO2011107007A1 Polyethylene glycol electrolyte granues and its preparing process |
| 09/09/2011 | WO2011106993A1 Gold nanoparticles modified by aminopyrimide, preparation method and use thereof |
| 09/09/2011 | WO2011106951A1 Compound pharmaceutical composition of levoamlodipine |
| 09/09/2011 | WO2011106858A1 Fast-dissolving solid pharmaceutical form for treating bacterial infections |
| 09/09/2011 | WO2011086577A3 Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts |
| 09/09/2011 | WO2011086331A3 Method for manufacturing capsules having controlled head |
| 09/09/2011 | WO2011084721A3 Cationic molecule and method of use |
| 09/09/2011 | WO2011080570A8 Extended release pharmaceutical composition comprising linezolid and process for preparing the same |